GeneDx

GeneDx is a leader in genomic diagnostics, specializing in delivering advanced genetic testing and data-driven insights to improve health outcomes. Originally founded as part of Sema4, GeneDx focuses on pediatric care, rare disease detection, and hereditary cancer screening. The company provides services like whole exome and genome sequencing, which are critical for diagnosing complex genetic disorders. Their genomic data platform, Centrellis, is powered by artificial intelligence (AI) and machine learning, enabling faster, more precise diagnoses by integrating clinical and genomic data.

GeneDx’s AI applications are primarily used to process and analyze vast amounts of genomic data, helping healthcare providers make informed decisions. They focus on personalized medicine, aiming to tailor treatments based on individual genetic profiles. This places the company in the AI-driven healthcare and genomics category, where AI is used to accelerate diagnostics and improve patient care.

GeneDx is based in Stamford, Connecticut, and is publicly traded on the Nasdaq under the ticker symbol “WGS”

GeneDx is based in Stamford, Connecticut, USA. Specializing in the AI industry, GeneDx pioneers innovative solutions and advancements in artificial intelligence. GeneDx, funded over $100 million, is well-positioned to drive significant impact and growth in the AI sector. For more information, please visit genedx.com.

To claim this startup page, go to the Contact page and send us a message with your full name, startup name, job title, and startup email address. We will review your request and get back to you. Once verified, you can update your startup information.